Review




Structured Review

Biacore binding activity
Binding Activity, supplied by Biacore, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/binding+activity/activity+binding/us12492239-65-26-34
Average 86 stars, based on 1 article reviews
binding activity - by Bioz Stars, 2026-10
86/100 stars

Images

Related Articles

Binding Assay:

Article Title: Antigen binding dimer-complexes, methods of making/avoiding and uses thereof
Article Snippet: More specifically, in the formulations of the present invention at least 80% (preferably at least 90%, more preferably at least 95% or even at least 99%) of the polypeptides retains its binding activity to at least one (preferably to all) of its targets (e.g. as assessed by ELISA and/or Biacore) after storage under one or more of the above stress conditions compared to the binding activity prior to storage. .. In a specific aspect, at least 80% (preferably at least 90%, more preferably at least 95% or even at least 99%) of the polypeptides retains its binding activity (e.g. as assessed by ELISA and/or Biacore) to at least one (preferably to all) of its targets after storage at 37±5° C. for up to at least 2 weeks (preferably at least 3 weeks, at least 5 weeks, at least 2 months, at least 6 months, at least 1 year, 1.5 year or even 2 years or more) compared to the binding activity prior to storage. .. Accordingly the present invention provides stable formulations of polypeptides comprising one or more single variable domains, wherein: less than 10% of the polypeptides forms dimers (e.g. as assessed by SE-HPLC) during storage at a temperature of 37±5° C. up to at least 2 weeks (preferably at least 3 weeks, at least 5 weeks, at least 8 weeks, at least 10 weeks, at least 3 months, at least 6 months, at least 1 year, 1.5 year or even 2 years or more); at least 80% of the polypeptides retain its binding activity (e.g. as assessed by ELISA and/or Biacore) to at least one (preferably to all) of its targets after storage at 37±5° C. up to 2 weeks (preferably at least 3 weeks, at least 5 weeks, at least 2 months, at least 6 months, at least 1 year, 1.5 year or even 2 years or more) compared to the binding activity prior to storage; and/or The present invention further provides methods for preparing the stable formulations of the invention.

Activity Assay:

Article Title: Antigen binding dimer-complexes, methods of making/avoiding and uses thereof
Article Snippet: More specifically, in the formulations of the present invention at least 80% (preferably at least 90%, more preferably at least 95% or even at least 99%) of the polypeptides retains its binding activity to at least one (preferably to all) of its targets (e.g. as assessed by ELISA and/or Biacore) after storage under one or more of the above stress conditions compared to the binding activity prior to storage. .. In a specific aspect, at least 80% (preferably at least 90%, more preferably at least 95% or even at least 99%) of the polypeptides retains its binding activity (e.g. as assessed by ELISA and/or Biacore) to at least one (preferably to all) of its targets after storage at 37±5° C. for up to at least 2 weeks (preferably at least 3 weeks, at least 5 weeks, at least 2 months, at least 6 months, at least 1 year, 1.5 year or even 2 years or more) compared to the binding activity prior to storage. .. Accordingly the present invention provides stable formulations of polypeptides comprising one or more single variable domains, wherein: less than 10% of the polypeptides forms dimers (e.g. as assessed by SE-HPLC) during storage at a temperature of 37±5° C. up to at least 2 weeks (preferably at least 3 weeks, at least 5 weeks, at least 8 weeks, at least 10 weeks, at least 3 months, at least 6 months, at least 1 year, 1.5 year or even 2 years or more); at least 80% of the polypeptides retain its binding activity (e.g. as assessed by ELISA and/or Biacore) to at least one (preferably to all) of its targets after storage at 37±5° C. up to 2 weeks (preferably at least 3 weeks, at least 5 weeks, at least 2 months, at least 6 months, at least 1 year, 1.5 year or even 2 years or more) compared to the binding activity prior to storage; and/or The present invention further provides methods for preparing the stable formulations of the invention.

Enzyme-linked Immunosorbent Assay:

Article Title: Antigen binding dimer-complexes, methods of making/avoiding and uses thereof
Article Snippet: More specifically, in the formulations of the present invention at least 80% (preferably at least 90%, more preferably at least 95% or even at least 99%) of the polypeptides retains its binding activity to at least one (preferably to all) of its targets (e.g. as assessed by ELISA and/or Biacore) after storage under one or more of the above stress conditions compared to the binding activity prior to storage. .. In a specific aspect, at least 80% (preferably at least 90%, more preferably at least 95% or even at least 99%) of the polypeptides retains its binding activity (e.g. as assessed by ELISA and/or Biacore) to at least one (preferably to all) of its targets after storage at 37±5° C. for up to at least 2 weeks (preferably at least 3 weeks, at least 5 weeks, at least 2 months, at least 6 months, at least 1 year, 1.5 year or even 2 years or more) compared to the binding activity prior to storage. .. Accordingly the present invention provides stable formulations of polypeptides comprising one or more single variable domains, wherein: less than 10% of the polypeptides forms dimers (e.g. as assessed by SE-HPLC) during storage at a temperature of 37±5° C. up to at least 2 weeks (preferably at least 3 weeks, at least 5 weeks, at least 8 weeks, at least 10 weeks, at least 3 months, at least 6 months, at least 1 year, 1.5 year or even 2 years or more); at least 80% of the polypeptides retain its binding activity (e.g. as assessed by ELISA and/or Biacore) to at least one (preferably to all) of its targets after storage at 37±5° C. up to 2 weeks (preferably at least 3 weeks, at least 5 weeks, at least 2 months, at least 6 months, at least 1 year, 1.5 year or even 2 years or more) compared to the binding activity prior to storage; and/or The present invention further provides methods for preparing the stable formulations of the invention.



Similar Products

94
Cytoskeleton Inc rhotekin rbd beads
Rhotekin Rbd Beads, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/binding+activity/Rhotekin-RBD+beads+-+binds+active+Rho+proteins/pm42785467-418-16-18
Average 94 stars, based on 1 article reviews
rhotekin rbd beads - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
Cytoskeleton Inc raf rbd protein gst beads
C283T immortalized melanocytes with doxycycline-inducible expression of RAPGEF1 were grown in supplement-free medium for 24hrs and subsequently treated with human EGF (hEGF) protein for the indicated time. A . Active GTP-bound RAP1 was pulled down by RalGDS-RBD beads from whole-cell extract. Pull-down and whole-cell (total RAP) fractions were compared by Western blotting with an antibody against RAP1. B . Active GTP-bound RAS was pulled down <t>by</t> <t>Raf-RBD</t> beads, with the pull-down and whole-cell (total RAS) fractions compared by Western blotting with an antibody against RAS. Active and total AKT and ERK were compared via Western blotting. The intensity of the phospho- versus total-AKT and ERK was determined by the ratio of the band intensity. Figures are representative experiments from three biological replicates.
Raf Rbd Protein Gst Beads, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/binding+activity/Raf-RBD+beads+-+binds+active+Ras+protein/pmc13641683-156-26-31
Average 94 stars, based on 1 article reviews
raf rbd protein gst beads - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

95
Cytoskeleton Inc pak pbd affinity beads
NISCH agonist rilmenidine reduces cell migration and invasion in vitro. ( a ) Quantification of the number of PDAC cells spread 6 and 24 h after seeding on tissue culture plastic, collagen I or fibronectin-coated surface in the presence of rilmenidine. Results were expressed as the percentage of spread cells out of the total counted per field. ( b ) Quantification of the PDAC cell migration in the wound healing assay after 24 h of treatment with rilmenidine; ( c ) Quantification of the PDAC cell migration in the transwell assay after 48 h of treatment with rilmenidine; ( d ) Level of active GTP-bound <t>Rac1</t> in PANC-1 cells from the wound healing assay 24 h post wounding in control or 100 μM rilmenidine-treated PANC1 cells, pulled–down from 600 μg lysate treated with 10 <t>μL</t> <t>PAK-PBD</t> beads; 20 ng of His-tagged Rac1 protein control, positive cellular protein control GTPγS loaded lysate, negative cellular protein control GTP loaded lysate; ( e ) Quantification of PDAC cell invasion through collagen I, fibronectin or matrigel in the transwell assay after 72 h of treatment with rilmenidine; ( f ) Representative images of transwell invasion through matrigel coat (right). Scale bar 200 μm. All data are shown as mean ± SD. n = 3; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, two-way ANOVA (Sidak’s multiple comparisons test).
Pak Pbd Affinity Beads, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/binding+activity/PAK-PBD+beads+-+binds+active+Rac+Cdc42+proteins/pmc13256129-205-8-14
Average 95 stars, based on 1 article reviews
pak pbd affinity beads - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

94
Cytoskeleton Inc glutathione stransferase conjugated rhotekin rbd beads
NISCH agonist rilmenidine reduces cell migration and invasion in vitro. ( a ) Quantification of the number of PDAC cells spread 6 and 24 h after seeding on tissue culture plastic, collagen I or fibronectin-coated surface in the presence of rilmenidine. Results were expressed as the percentage of spread cells out of the total counted per field. ( b ) Quantification of the PDAC cell migration in the wound healing assay after 24 h of treatment with rilmenidine; ( c ) Quantification of the PDAC cell migration in the transwell assay after 48 h of treatment with rilmenidine; ( d ) Level of active GTP-bound <t>Rac1</t> in PANC-1 cells from the wound healing assay 24 h post wounding in control or 100 μM rilmenidine-treated PANC1 cells, pulled–down from 600 μg lysate treated with 10 <t>μL</t> <t>PAK-PBD</t> beads; 20 ng of His-tagged Rac1 protein control, positive cellular protein control GTPγS loaded lysate, negative cellular protein control GTP loaded lysate; ( e ) Quantification of PDAC cell invasion through collagen I, fibronectin or matrigel in the transwell assay after 72 h of treatment with rilmenidine; ( f ) Representative images of transwell invasion through matrigel coat (right). Scale bar 200 μm. All data are shown as mean ± SD. n = 3; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, two-way ANOVA (Sidak’s multiple comparisons test).
Glutathione Stransferase Conjugated Rhotekin Rbd Beads, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/binding+activity/Rhotekin-RBD+beads+-+binds+active+Rho+proteins/pm42192125-442-16-21
Average 94 stars, based on 1 article reviews
glutathione stransferase conjugated rhotekin rbd beads - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

95
Cytoskeleton Inc active rac1 pak 02
a , Immunoblots showing cleaved Notch1 (c-Notch1) and total Notch1 in MVECs treated with S1P for 1-hour ± γ-secretase inhibitor DAPT; quantification below (mean ± SEM). b , Fluorescent micrographs of YFP-Notch1 reporter intensity after S1P treatment; quantification below. Scale bar, 50 μm. c-d , Fold change in HES1 and HEY1 gene expression levels in (c) MVECs after S1P ± DAPT treatment, and in (d) mouse tissues after intravenous injection of S1P ± DAPT. e , Evans blue dye leakage in mouse dermis 1-hour post-injection with DMSO, S1P, or S1P + DAPT. Scale bar, 5 mm. f-i , Quantified dye leakage in (f) dermis, (g) lung, (h) liver, and (i) kidney, measured via absorbance. j , Heat maps of dextran dye diffusion in engineered microvessels ± S1P. Scale bar, 50 μm. k-l , Diffusive permeability in microvessels lined with (k) DAPT-vs. DMSO-treated or (l) NOTCH1 KO vs. SCR KO MVECs (mean ± SD). m , Micrographs of VE-cadherin (magenta), actin (green), and nuclei (blue) staining in microvessels. Scale bar, 50 μm. n-o , Mean corrected intensities of junctional (n) VE-cadherin and (o) actin from (m). p , <t>Rac1</t> activity (PBD pull-down). Active/total Rac1 quantification below. q , Schematic of canonical Notch signaling. r , HES1 / HEY1 gene expression levels in dominant negative-MAML-GFP (DN-MAML-GFP) normalized to GFP expressing cells. s , Permeability in DN-MAML-GFP vs GFP-lined microvessels ± S1P. t , Schematic of Notch cortical pathway mediated by its transmembrane domain (TMD). u , Permeability in TMD-RFP vs RFP-lined microvessels ± S1P. v , Permeability in TMD-RFP vs RFP-lined microvessels ± clinical S1P receptor degrader fingolimod.
Active Rac1 Pak 02, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/binding+activity/PAK-PBD+beads+-+binds+active+Rac+Cdc42+proteins/bio_rxiv__64898__2026__05__20__726610-282-4-10
Average 95 stars, based on 1 article reviews
active rac1 pak 02 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

95
Cytoskeleton Inc gst pak pbd beads
a , b , Addition of FBP to whole cell lysate causes a conformational change in Rac1. a , Whole cell lysates of U-2 OS cells were subjected to LiP–MS. Peptide intensity (amino acids (aa) 6–16) of Rac1 in response to increasing FBP concentrations. b , Responding peptide (red, aa 6–16) highlighted in the GTP-bound structure of Rac1 (PDB ID: 1MH1 ). c , Increased Rac1 activity upon loss of aldolase. Left: representative immunoblot of pull-down <t>assay</t> <t>using</t> <t>GST-PAK-PBD</t> beads to detect active Rac1 in lysates from siRNA treated U-2 OS cells. α-Tubulin was used as a loading control. Right: a quantification of Rac1-GTP over total Rac1. Data were normalized to siCtrl and represent mean ± s.e.m.; n = 5 independent experiments; two-sided one-sample t -test ( P value = 0.0326). d , Efficient Rac1 depletion. Representative immunoblot of U-2 OS cells treated with the indicated siRNAs. β-actin and clathrin heavy chain (CHC) were used as loading controls; N = 3 independent experiments. e , Codepletion of Rac1 does not significantly lower FBP levels in aldolase-knockdown cells. Relative FBP levels measured in U-2 OS cells treated with indicated siRNAs. Data were normalized to siCtrl and represent mean ± s.e.m.; n = 3 independent experiments; two-sided one-sample t -test ( P values: (siRAC1) = 0.1494; (siALDOA) = 0.027; (siRAC1 + siALDOA) = 0.105). f – h , Codepletion of Rac1 restores FA numbers and cell size in aldolase knockdown cells. f , Representative confocal images of paxillin-labelled FAs in U-2 OS cells treated with indicated siRNAs. FA segmentation and cell outlines (red) are shown below. g , h , A quantification of FAs per cell ( f ) and cell area ( g ) shown in f . For f – h , data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values (for g ): (siCtrl versus siRAC1) = 0.0481; (siCtrl versus siALDOA) <0.0001; (siCtrl versus siRAC1 + siALDOA) = 0.9979; P values (for h ): (siCtrl versus siRAC1) = 0.0003; (siCtrl versus siALDOA) <0.0001; (siCtrl versus siRAC1 + siALDOA) = 0.2799). i , j , Expression of dominant-negative Rac1 in aldolase-depleted cells rescues increased FA numbers ( i ) and cell size ( j ). A quantification of FAs per cell and cell area of U-2 OS cells transfected with control (−) or ALDOA-specific (+) siRNAs in combination with either eGFP or myc-Rac1-T17N. Corresponding images are shown in Extended Data Fig. . Data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values (for i ): (siCtrl + GFP versus siCtrl + T17N) = 0.1497; (siCtrl + GFP versus siALDOA + GFP) <0.0001; (siCtrl + GFP versus siALDOA + T17N) = 0.0633; P values (for j ): (siCtrl + GFP versus siCtrl + T17N) = 0.4683; (siCtrl + GFP versus siALDOA + GFP) <0.0001; (siCtrl + GFP versus siALDOA + T17N) = 0.0981). k , l , Expression of constitutively active Rac1 in PFK-depleted cells rescues reduced FA numbers and cell size. Quantifications of FAs per cell ( k ) and cell area ( l ) of U-2 OS cells transfected with control (−) or PFK-specific (+) siRNAs in combination with either eGFP or myc-Rac1-Q61L. Corresponding images are shown in Extended Data Fig. . Data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values (for k ): (siCtrl + GFP versus siCtrl + Rac1-Q61L) = 0.0342; (siCtrl + GFP versus siPFK + GFP) = 0.0063; (siCtrl + GFP versus siPFK + Rac1-Q61L) = 0.8904; P values (for l ): (siCtrl + GFP versus siCtrl + Rac1-Q61L) <0.0001; (siCtrl + GFP versus siPFK + GFP) = 0.0116; (siCtrl + GFP versus siPFK + Rac1-Q61L) = 0.0004). n.s., not significant; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. Scale bars, 25 µm.
Gst Pak Pbd Beads, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/binding+activity/PAK-PBD+beads+-+binds+active+Rac+Cdc42+proteins/pmc13086585-476-10-12
Average 95 stars, based on 1 article reviews
gst pak pbd beads - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

94
Cytoskeleton Inc raf rbd beads
a , b , Addition of FBP to whole cell lysate causes a conformational change in Rac1. a , Whole cell lysates of U-2 OS cells were subjected to LiP–MS. Peptide intensity (amino acids (aa) 6–16) of Rac1 in response to increasing FBP concentrations. b , Responding peptide (red, aa 6–16) highlighted in the GTP-bound structure of Rac1 (PDB ID: 1MH1 ). c , Increased Rac1 activity upon loss of aldolase. Left: representative immunoblot of pull-down <t>assay</t> <t>using</t> <t>GST-PAK-PBD</t> beads to detect active Rac1 in lysates from siRNA treated U-2 OS cells. α-Tubulin was used as a loading control. Right: a quantification of Rac1-GTP over total Rac1. Data were normalized to siCtrl and represent mean ± s.e.m.; n = 5 independent experiments; two-sided one-sample t -test ( P value = 0.0326). d , Efficient Rac1 depletion. Representative immunoblot of U-2 OS cells treated with the indicated siRNAs. β-actin and clathrin heavy chain (CHC) were used as loading controls; N = 3 independent experiments. e , Codepletion of Rac1 does not significantly lower FBP levels in aldolase-knockdown cells. Relative FBP levels measured in U-2 OS cells treated with indicated siRNAs. Data were normalized to siCtrl and represent mean ± s.e.m.; n = 3 independent experiments; two-sided one-sample t -test ( P values: (siRAC1) = 0.1494; (siALDOA) = 0.027; (siRAC1 + siALDOA) = 0.105). f – h , Codepletion of Rac1 restores FA numbers and cell size in aldolase knockdown cells. f , Representative confocal images of paxillin-labelled FAs in U-2 OS cells treated with indicated siRNAs. FA segmentation and cell outlines (red) are shown below. g , h , A quantification of FAs per cell ( f ) and cell area ( g ) shown in f . For f – h , data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values (for g ): (siCtrl versus siRAC1) = 0.0481; (siCtrl versus siALDOA) <0.0001; (siCtrl versus siRAC1 + siALDOA) = 0.9979; P values (for h ): (siCtrl versus siRAC1) = 0.0003; (siCtrl versus siALDOA) <0.0001; (siCtrl versus siRAC1 + siALDOA) = 0.2799). i , j , Expression of dominant-negative Rac1 in aldolase-depleted cells rescues increased FA numbers ( i ) and cell size ( j ). A quantification of FAs per cell and cell area of U-2 OS cells transfected with control (−) or ALDOA-specific (+) siRNAs in combination with either eGFP or myc-Rac1-T17N. Corresponding images are shown in Extended Data Fig. . Data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values (for i ): (siCtrl + GFP versus siCtrl + T17N) = 0.1497; (siCtrl + GFP versus siALDOA + GFP) <0.0001; (siCtrl + GFP versus siALDOA + T17N) = 0.0633; P values (for j ): (siCtrl + GFP versus siCtrl + T17N) = 0.4683; (siCtrl + GFP versus siALDOA + GFP) <0.0001; (siCtrl + GFP versus siALDOA + T17N) = 0.0981). k , l , Expression of constitutively active Rac1 in PFK-depleted cells rescues reduced FA numbers and cell size. Quantifications of FAs per cell ( k ) and cell area ( l ) of U-2 OS cells transfected with control (−) or PFK-specific (+) siRNAs in combination with either eGFP or myc-Rac1-Q61L. Corresponding images are shown in Extended Data Fig. . Data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values (for k ): (siCtrl + GFP versus siCtrl + Rac1-Q61L) = 0.0342; (siCtrl + GFP versus siPFK + GFP) = 0.0063; (siCtrl + GFP versus siPFK + Rac1-Q61L) = 0.8904; P values (for l ): (siCtrl + GFP versus siCtrl + Rac1-Q61L) <0.0001; (siCtrl + GFP versus siPFK + GFP) = 0.0116; (siCtrl + GFP versus siPFK + Rac1-Q61L) = 0.0004). n.s., not significant; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. Scale bars, 25 µm.
Raf Rbd Beads, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/binding+activity/Raf-RBD+beads+-+binds+active+Ras+protein/bio_rxiv__64898__2026__02__26__708383-230-16-18
Average 94 stars, based on 1 article reviews
raf rbd beads - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

93
Developmental Studies Hybridoma Bank pcrp g3bp1 2h8
a , b , Addition of FBP to whole cell lysate causes a conformational change in Rac1. a , Whole cell lysates of U-2 OS cells were subjected to LiP–MS. Peptide intensity (amino acids (aa) 6–16) of Rac1 in response to increasing FBP concentrations. b , Responding peptide (red, aa 6–16) highlighted in the GTP-bound structure of Rac1 (PDB ID: 1MH1 ). c , Increased Rac1 activity upon loss of aldolase. Left: representative immunoblot of pull-down <t>assay</t> <t>using</t> <t>GST-PAK-PBD</t> beads to detect active Rac1 in lysates from siRNA treated U-2 OS cells. α-Tubulin was used as a loading control. Right: a quantification of Rac1-GTP over total Rac1. Data were normalized to siCtrl and represent mean ± s.e.m.; n = 5 independent experiments; two-sided one-sample t -test ( P value = 0.0326). d , Efficient Rac1 depletion. Representative immunoblot of U-2 OS cells treated with the indicated siRNAs. β-actin and clathrin heavy chain (CHC) were used as loading controls; N = 3 independent experiments. e , Codepletion of Rac1 does not significantly lower FBP levels in aldolase-knockdown cells. Relative FBP levels measured in U-2 OS cells treated with indicated siRNAs. Data were normalized to siCtrl and represent mean ± s.e.m.; n = 3 independent experiments; two-sided one-sample t -test ( P values: (siRAC1) = 0.1494; (siALDOA) = 0.027; (siRAC1 + siALDOA) = 0.105). f – h , Codepletion of Rac1 restores FA numbers and cell size in aldolase knockdown cells. f , Representative confocal images of paxillin-labelled FAs in U-2 OS cells treated with indicated siRNAs. FA segmentation and cell outlines (red) are shown below. g , h , A quantification of FAs per cell ( f ) and cell area ( g ) shown in f . For f – h , data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values (for g ): (siCtrl versus siRAC1) = 0.0481; (siCtrl versus siALDOA) <0.0001; (siCtrl versus siRAC1 + siALDOA) = 0.9979; P values (for h ): (siCtrl versus siRAC1) = 0.0003; (siCtrl versus siALDOA) <0.0001; (siCtrl versus siRAC1 + siALDOA) = 0.2799). i , j , Expression of dominant-negative Rac1 in aldolase-depleted cells rescues increased FA numbers ( i ) and cell size ( j ). A quantification of FAs per cell and cell area of U-2 OS cells transfected with control (−) or ALDOA-specific (+) siRNAs in combination with either eGFP or myc-Rac1-T17N. Corresponding images are shown in Extended Data Fig. . Data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values (for i ): (siCtrl + GFP versus siCtrl + T17N) = 0.1497; (siCtrl + GFP versus siALDOA + GFP) <0.0001; (siCtrl + GFP versus siALDOA + T17N) = 0.0633; P values (for j ): (siCtrl + GFP versus siCtrl + T17N) = 0.4683; (siCtrl + GFP versus siALDOA + GFP) <0.0001; (siCtrl + GFP versus siALDOA + T17N) = 0.0981). k , l , Expression of constitutively active Rac1 in PFK-depleted cells rescues reduced FA numbers and cell size. Quantifications of FAs per cell ( k ) and cell area ( l ) of U-2 OS cells transfected with control (−) or PFK-specific (+) siRNAs in combination with either eGFP or myc-Rac1-Q61L. Corresponding images are shown in Extended Data Fig. . Data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values (for k ): (siCtrl + GFP versus siCtrl + Rac1-Q61L) = 0.0342; (siCtrl + GFP versus siPFK + GFP) = 0.0063; (siCtrl + GFP versus siPFK + Rac1-Q61L) = 0.8904; P values (for l ): (siCtrl + GFP versus siCtrl + Rac1-Q61L) <0.0001; (siCtrl + GFP versus siPFK + GFP) = 0.0116; (siCtrl + GFP versus siPFK + Rac1-Q61L) = 0.0004). n.s., not significant; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. Scale bars, 25 µm.
Pcrp G3bp1 2h8, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/binding+activity/anti-Ras+GTPase-activating+protein-binding+protein+1/bio_rxiv__64898__2026__02__06__704442-316-2-1
Average 93 stars, based on 1 article reviews
pcrp g3bp1 2h8 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

95
Cytoskeleton Inc gst tagged pak pbd beads
a , b , Addition of FBP to whole cell lysate causes a conformational change in Rac1. a , Whole cell lysates of U-2 OS cells were subjected to LiP–MS. Peptide intensity (amino acids (aa) 6–16) of Rac1 in response to increasing FBP concentrations. b , Responding peptide (red, aa 6–16) highlighted in the GTP-bound structure of Rac1 (PDB ID: 1MH1 ). c , Increased Rac1 activity upon loss of aldolase. Left: representative immunoblot of pull-down <t>assay</t> <t>using</t> <t>GST-PAK-PBD</t> beads to detect active Rac1 in lysates from siRNA treated U-2 OS cells. α-Tubulin was used as a loading control. Right: a quantification of Rac1-GTP over total Rac1. Data were normalized to siCtrl and represent mean ± s.e.m.; n = 5 independent experiments; two-sided one-sample t -test ( P value = 0.0326). d , Efficient Rac1 depletion. Representative immunoblot of U-2 OS cells treated with the indicated siRNAs. β-actin and clathrin heavy chain (CHC) were used as loading controls; N = 3 independent experiments. e , Codepletion of Rac1 does not significantly lower FBP levels in aldolase-knockdown cells. Relative FBP levels measured in U-2 OS cells treated with indicated siRNAs. Data were normalized to siCtrl and represent mean ± s.e.m.; n = 3 independent experiments; two-sided one-sample t -test ( P values: (siRAC1) = 0.1494; (siALDOA) = 0.027; (siRAC1 + siALDOA) = 0.105). f – h , Codepletion of Rac1 restores FA numbers and cell size in aldolase knockdown cells. f , Representative confocal images of paxillin-labelled FAs in U-2 OS cells treated with indicated siRNAs. FA segmentation and cell outlines (red) are shown below. g , h , A quantification of FAs per cell ( f ) and cell area ( g ) shown in f . For f – h , data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values (for g ): (siCtrl versus siRAC1) = 0.0481; (siCtrl versus siALDOA) <0.0001; (siCtrl versus siRAC1 + siALDOA) = 0.9979; P values (for h ): (siCtrl versus siRAC1) = 0.0003; (siCtrl versus siALDOA) <0.0001; (siCtrl versus siRAC1 + siALDOA) = 0.2799). i , j , Expression of dominant-negative Rac1 in aldolase-depleted cells rescues increased FA numbers ( i ) and cell size ( j ). A quantification of FAs per cell and cell area of U-2 OS cells transfected with control (−) or ALDOA-specific (+) siRNAs in combination with either eGFP or myc-Rac1-T17N. Corresponding images are shown in Extended Data Fig. . Data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values (for i ): (siCtrl + GFP versus siCtrl + T17N) = 0.1497; (siCtrl + GFP versus siALDOA + GFP) <0.0001; (siCtrl + GFP versus siALDOA + T17N) = 0.0633; P values (for j ): (siCtrl + GFP versus siCtrl + T17N) = 0.4683; (siCtrl + GFP versus siALDOA + GFP) <0.0001; (siCtrl + GFP versus siALDOA + T17N) = 0.0981). k , l , Expression of constitutively active Rac1 in PFK-depleted cells rescues reduced FA numbers and cell size. Quantifications of FAs per cell ( k ) and cell area ( l ) of U-2 OS cells transfected with control (−) or PFK-specific (+) siRNAs in combination with either eGFP or myc-Rac1-Q61L. Corresponding images are shown in Extended Data Fig. . Data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values (for k ): (siCtrl + GFP versus siCtrl + Rac1-Q61L) = 0.0342; (siCtrl + GFP versus siPFK + GFP) = 0.0063; (siCtrl + GFP versus siPFK + Rac1-Q61L) = 0.8904; P values (for l ): (siCtrl + GFP versus siCtrl + Rac1-Q61L) <0.0001; (siCtrl + GFP versus siPFK + GFP) = 0.0116; (siCtrl + GFP versus siPFK + Rac1-Q61L) = 0.0004). n.s., not significant; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. Scale bars, 25 µm.
Gst Tagged Pak Pbd Beads, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/binding+activity/PAK-PBD+beads+-+binds+active+Rac+Cdc42+proteins/pm41638201-290-4-7
Average 95 stars, based on 1 article reviews
gst tagged pak pbd beads - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

95
Cytoskeleton Inc activation assay kit
a , b , Addition of FBP to whole cell lysate causes a conformational change in Rac1. a , Whole cell lysates of U-2 OS cells were subjected to LiP–MS. Peptide intensity (amino acids (aa) 6–16) of Rac1 in response to increasing FBP concentrations. b , Responding peptide (red, aa 6–16) highlighted in the GTP-bound structure of Rac1 (PDB ID: 1MH1 ). c , Increased Rac1 activity upon loss of aldolase. Left: representative immunoblot of pull-down <t>assay</t> <t>using</t> <t>GST-PAK-PBD</t> beads to detect active Rac1 in lysates from siRNA treated U-2 OS cells. α-Tubulin was used as a loading control. Right: a quantification of Rac1-GTP over total Rac1. Data were normalized to siCtrl and represent mean ± s.e.m.; n = 5 independent experiments; two-sided one-sample t -test ( P value = 0.0326). d , Efficient Rac1 depletion. Representative immunoblot of U-2 OS cells treated with the indicated siRNAs. β-actin and clathrin heavy chain (CHC) were used as loading controls; N = 3 independent experiments. e , Codepletion of Rac1 does not significantly lower FBP levels in aldolase-knockdown cells. Relative FBP levels measured in U-2 OS cells treated with indicated siRNAs. Data were normalized to siCtrl and represent mean ± s.e.m.; n = 3 independent experiments; two-sided one-sample t -test ( P values: (siRAC1) = 0.1494; (siALDOA) = 0.027; (siRAC1 + siALDOA) = 0.105). f – h , Codepletion of Rac1 restores FA numbers and cell size in aldolase knockdown cells. f , Representative confocal images of paxillin-labelled FAs in U-2 OS cells treated with indicated siRNAs. FA segmentation and cell outlines (red) are shown below. g , h , A quantification of FAs per cell ( f ) and cell area ( g ) shown in f . For f – h , data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values (for g ): (siCtrl versus siRAC1) = 0.0481; (siCtrl versus siALDOA) <0.0001; (siCtrl versus siRAC1 + siALDOA) = 0.9979; P values (for h ): (siCtrl versus siRAC1) = 0.0003; (siCtrl versus siALDOA) <0.0001; (siCtrl versus siRAC1 + siALDOA) = 0.2799). i , j , Expression of dominant-negative Rac1 in aldolase-depleted cells rescues increased FA numbers ( i ) and cell size ( j ). A quantification of FAs per cell and cell area of U-2 OS cells transfected with control (−) or ALDOA-specific (+) siRNAs in combination with either eGFP or myc-Rac1-T17N. Corresponding images are shown in Extended Data Fig. . Data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values (for i ): (siCtrl + GFP versus siCtrl + T17N) = 0.1497; (siCtrl + GFP versus siALDOA + GFP) <0.0001; (siCtrl + GFP versus siALDOA + T17N) = 0.0633; P values (for j ): (siCtrl + GFP versus siCtrl + T17N) = 0.4683; (siCtrl + GFP versus siALDOA + GFP) <0.0001; (siCtrl + GFP versus siALDOA + T17N) = 0.0981). k , l , Expression of constitutively active Rac1 in PFK-depleted cells rescues reduced FA numbers and cell size. Quantifications of FAs per cell ( k ) and cell area ( l ) of U-2 OS cells transfected with control (−) or PFK-specific (+) siRNAs in combination with either eGFP or myc-Rac1-Q61L. Corresponding images are shown in Extended Data Fig. . Data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values (for k ): (siCtrl + GFP versus siCtrl + Rac1-Q61L) = 0.0342; (siCtrl + GFP versus siPFK + GFP) = 0.0063; (siCtrl + GFP versus siPFK + Rac1-Q61L) = 0.8904; P values (for l ): (siCtrl + GFP versus siCtrl + Rac1-Q61L) <0.0001; (siCtrl + GFP versus siPFK + GFP) = 0.0116; (siCtrl + GFP versus siPFK + Rac1-Q61L) = 0.0004). n.s., not significant; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. Scale bars, 25 µm.
Activation Assay Kit, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/binding+activity/PAK-PBD+beads+-+binds+active+Rac+Cdc42+proteins/pmc12765065-283-15-18
Average 95 stars, based on 1 article reviews
activation assay kit - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

Image Search Results


C283T immortalized melanocytes with doxycycline-inducible expression of RAPGEF1 were grown in supplement-free medium for 24hrs and subsequently treated with human EGF (hEGF) protein for the indicated time. A . Active GTP-bound RAP1 was pulled down by RalGDS-RBD beads from whole-cell extract. Pull-down and whole-cell (total RAP) fractions were compared by Western blotting with an antibody against RAP1. B . Active GTP-bound RAS was pulled down by Raf-RBD beads, with the pull-down and whole-cell (total RAS) fractions compared by Western blotting with an antibody against RAS. Active and total AKT and ERK were compared via Western blotting. The intensity of the phospho- versus total-AKT and ERK was determined by the ratio of the band intensity. Figures are representative experiments from three biological replicates.

Journal: American journal of human genetics

Article Title: Functional characterization of the 9q34.13 locus identifies RAPGEF1 as a candidate gene modulating risk for melanoma and nevi via RAS activation

doi: 10.1016/j.ajhg.2026.08.014

Figure Lengend Snippet: C283T immortalized melanocytes with doxycycline-inducible expression of RAPGEF1 were grown in supplement-free medium for 24hrs and subsequently treated with human EGF (hEGF) protein for the indicated time. A . Active GTP-bound RAP1 was pulled down by RalGDS-RBD beads from whole-cell extract. Pull-down and whole-cell (total RAP) fractions were compared by Western blotting with an antibody against RAP1. B . Active GTP-bound RAS was pulled down by Raf-RBD beads, with the pull-down and whole-cell (total RAS) fractions compared by Western blotting with an antibody against RAS. Active and total AKT and ERK were compared via Western blotting. The intensity of the phospho- versus total-AKT and ERK was determined by the ratio of the band intensity. Figures are representative experiments from three biological replicates.

Article Snippet: RAP1 activation was measured using the RAP1 activation assay kit from Abcam (ab212011) and RAS activation was measured using GST-fusion Raf-1 RBD beads (Sigma, #14863) or RAF-RBD Protein GST Beads (RF02-A, Cytoskeleton).

Techniques: Activation Assay, Expressing, Pull Down Assay, Western Blot

NISCH agonist rilmenidine reduces cell migration and invasion in vitro. ( a ) Quantification of the number of PDAC cells spread 6 and 24 h after seeding on tissue culture plastic, collagen I or fibronectin-coated surface in the presence of rilmenidine. Results were expressed as the percentage of spread cells out of the total counted per field. ( b ) Quantification of the PDAC cell migration in the wound healing assay after 24 h of treatment with rilmenidine; ( c ) Quantification of the PDAC cell migration in the transwell assay after 48 h of treatment with rilmenidine; ( d ) Level of active GTP-bound Rac1 in PANC-1 cells from the wound healing assay 24 h post wounding in control or 100 μM rilmenidine-treated PANC1 cells, pulled–down from 600 μg lysate treated with 10 μL PAK-PBD beads; 20 ng of His-tagged Rac1 protein control, positive cellular protein control GTPγS loaded lysate, negative cellular protein control GTP loaded lysate; ( e ) Quantification of PDAC cell invasion through collagen I, fibronectin or matrigel in the transwell assay after 72 h of treatment with rilmenidine; ( f ) Representative images of transwell invasion through matrigel coat (right). Scale bar 200 μm. All data are shown as mean ± SD. n = 3; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, two-way ANOVA (Sidak’s multiple comparisons test).

Journal: Cells

Article Title: Repurposing Rilmenidine as a Potential Antimetastatic Therapy Targeting Nischarin in Pancreatic Ductal Adenocarcinoma

doi: 10.3390/cells15111032

Figure Lengend Snippet: NISCH agonist rilmenidine reduces cell migration and invasion in vitro. ( a ) Quantification of the number of PDAC cells spread 6 and 24 h after seeding on tissue culture plastic, collagen I or fibronectin-coated surface in the presence of rilmenidine. Results were expressed as the percentage of spread cells out of the total counted per field. ( b ) Quantification of the PDAC cell migration in the wound healing assay after 24 h of treatment with rilmenidine; ( c ) Quantification of the PDAC cell migration in the transwell assay after 48 h of treatment with rilmenidine; ( d ) Level of active GTP-bound Rac1 in PANC-1 cells from the wound healing assay 24 h post wounding in control or 100 μM rilmenidine-treated PANC1 cells, pulled–down from 600 μg lysate treated with 10 μL PAK-PBD beads; 20 ng of His-tagged Rac1 protein control, positive cellular protein control GTPγS loaded lysate, negative cellular protein control GTP loaded lysate; ( e ) Quantification of PDAC cell invasion through collagen I, fibronectin or matrigel in the transwell assay after 72 h of treatment with rilmenidine; ( f ) Representative images of transwell invasion through matrigel coat (right). Scale bar 200 μm. All data are shown as mean ± SD. n = 3; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, two-way ANOVA (Sidak’s multiple comparisons test).

Article Snippet: We pulled-down GTP-bound Rac1 in PANC-1 cells with PAK-PBD affinity beads (Rac1 Activation Assay, Cytoskeleton) 24 h after introduction of multiple wounds in a confluent layer of cells in absence or presence of 100 μM rilmenidine.

Techniques: Migration, In Vitro, Wound Healing Assay, Transwell Assay, Control

a , Immunoblots showing cleaved Notch1 (c-Notch1) and total Notch1 in MVECs treated with S1P for 1-hour ± γ-secretase inhibitor DAPT; quantification below (mean ± SEM). b , Fluorescent micrographs of YFP-Notch1 reporter intensity after S1P treatment; quantification below. Scale bar, 50 μm. c-d , Fold change in HES1 and HEY1 gene expression levels in (c) MVECs after S1P ± DAPT treatment, and in (d) mouse tissues after intravenous injection of S1P ± DAPT. e , Evans blue dye leakage in mouse dermis 1-hour post-injection with DMSO, S1P, or S1P + DAPT. Scale bar, 5 mm. f-i , Quantified dye leakage in (f) dermis, (g) lung, (h) liver, and (i) kidney, measured via absorbance. j , Heat maps of dextran dye diffusion in engineered microvessels ± S1P. Scale bar, 50 μm. k-l , Diffusive permeability in microvessels lined with (k) DAPT-vs. DMSO-treated or (l) NOTCH1 KO vs. SCR KO MVECs (mean ± SD). m , Micrographs of VE-cadherin (magenta), actin (green), and nuclei (blue) staining in microvessels. Scale bar, 50 μm. n-o , Mean corrected intensities of junctional (n) VE-cadherin and (o) actin from (m). p , Rac1 activity (PBD pull-down). Active/total Rac1 quantification below. q , Schematic of canonical Notch signaling. r , HES1 / HEY1 gene expression levels in dominant negative-MAML-GFP (DN-MAML-GFP) normalized to GFP expressing cells. s , Permeability in DN-MAML-GFP vs GFP-lined microvessels ± S1P. t , Schematic of Notch cortical pathway mediated by its transmembrane domain (TMD). u , Permeability in TMD-RFP vs RFP-lined microvessels ± S1P. v , Permeability in TMD-RFP vs RFP-lined microvessels ± clinical S1P receptor degrader fingolimod.

Journal: bioRxiv

Article Title: Sphingosine-1-phosphate cross-talks to Notch via a S1PR1-Dll4-MPDZ complex to regulate endothelial barrier function

doi: 10.64898/2026.05.20.726610

Figure Lengend Snippet: a , Immunoblots showing cleaved Notch1 (c-Notch1) and total Notch1 in MVECs treated with S1P for 1-hour ± γ-secretase inhibitor DAPT; quantification below (mean ± SEM). b , Fluorescent micrographs of YFP-Notch1 reporter intensity after S1P treatment; quantification below. Scale bar, 50 μm. c-d , Fold change in HES1 and HEY1 gene expression levels in (c) MVECs after S1P ± DAPT treatment, and in (d) mouse tissues after intravenous injection of S1P ± DAPT. e , Evans blue dye leakage in mouse dermis 1-hour post-injection with DMSO, S1P, or S1P + DAPT. Scale bar, 5 mm. f-i , Quantified dye leakage in (f) dermis, (g) lung, (h) liver, and (i) kidney, measured via absorbance. j , Heat maps of dextran dye diffusion in engineered microvessels ± S1P. Scale bar, 50 μm. k-l , Diffusive permeability in microvessels lined with (k) DAPT-vs. DMSO-treated or (l) NOTCH1 KO vs. SCR KO MVECs (mean ± SD). m , Micrographs of VE-cadherin (magenta), actin (green), and nuclei (blue) staining in microvessels. Scale bar, 50 μm. n-o , Mean corrected intensities of junctional (n) VE-cadherin and (o) actin from (m). p , Rac1 activity (PBD pull-down). Active/total Rac1 quantification below. q , Schematic of canonical Notch signaling. r , HES1 / HEY1 gene expression levels in dominant negative-MAML-GFP (DN-MAML-GFP) normalized to GFP expressing cells. s , Permeability in DN-MAML-GFP vs GFP-lined microvessels ± S1P. t , Schematic of Notch cortical pathway mediated by its transmembrane domain (TMD). u , Permeability in TMD-RFP vs RFP-lined microvessels ± S1P. v , Permeability in TMD-RFP vs RFP-lined microvessels ± clinical S1P receptor degrader fingolimod.

Article Snippet: PAK-PBD beads to bind active Rac1 (PAK-02) were purchased from Cytoskeleton and reconstituted according to the manufacturer’s instructions.

Techniques: Western Blot, Gene Expression, Injection, Diffusion-based Assay, Permeability, Staining, Activity Assay, Dominant Negative Mutation, Expressing

a , b , Addition of FBP to whole cell lysate causes a conformational change in Rac1. a , Whole cell lysates of U-2 OS cells were subjected to LiP–MS. Peptide intensity (amino acids (aa) 6–16) of Rac1 in response to increasing FBP concentrations. b , Responding peptide (red, aa 6–16) highlighted in the GTP-bound structure of Rac1 (PDB ID: 1MH1 ). c , Increased Rac1 activity upon loss of aldolase. Left: representative immunoblot of pull-down assay using GST-PAK-PBD beads to detect active Rac1 in lysates from siRNA treated U-2 OS cells. α-Tubulin was used as a loading control. Right: a quantification of Rac1-GTP over total Rac1. Data were normalized to siCtrl and represent mean ± s.e.m.; n = 5 independent experiments; two-sided one-sample t -test ( P value = 0.0326). d , Efficient Rac1 depletion. Representative immunoblot of U-2 OS cells treated with the indicated siRNAs. β-actin and clathrin heavy chain (CHC) were used as loading controls; N = 3 independent experiments. e , Codepletion of Rac1 does not significantly lower FBP levels in aldolase-knockdown cells. Relative FBP levels measured in U-2 OS cells treated with indicated siRNAs. Data were normalized to siCtrl and represent mean ± s.e.m.; n = 3 independent experiments; two-sided one-sample t -test ( P values: (siRAC1) = 0.1494; (siALDOA) = 0.027; (siRAC1 + siALDOA) = 0.105). f – h , Codepletion of Rac1 restores FA numbers and cell size in aldolase knockdown cells. f , Representative confocal images of paxillin-labelled FAs in U-2 OS cells treated with indicated siRNAs. FA segmentation and cell outlines (red) are shown below. g , h , A quantification of FAs per cell ( f ) and cell area ( g ) shown in f . For f – h , data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values (for g ): (siCtrl versus siRAC1) = 0.0481; (siCtrl versus siALDOA) <0.0001; (siCtrl versus siRAC1 + siALDOA) = 0.9979; P values (for h ): (siCtrl versus siRAC1) = 0.0003; (siCtrl versus siALDOA) <0.0001; (siCtrl versus siRAC1 + siALDOA) = 0.2799). i , j , Expression of dominant-negative Rac1 in aldolase-depleted cells rescues increased FA numbers ( i ) and cell size ( j ). A quantification of FAs per cell and cell area of U-2 OS cells transfected with control (−) or ALDOA-specific (+) siRNAs in combination with either eGFP or myc-Rac1-T17N. Corresponding images are shown in Extended Data Fig. . Data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values (for i ): (siCtrl + GFP versus siCtrl + T17N) = 0.1497; (siCtrl + GFP versus siALDOA + GFP) <0.0001; (siCtrl + GFP versus siALDOA + T17N) = 0.0633; P values (for j ): (siCtrl + GFP versus siCtrl + T17N) = 0.4683; (siCtrl + GFP versus siALDOA + GFP) <0.0001; (siCtrl + GFP versus siALDOA + T17N) = 0.0981). k , l , Expression of constitutively active Rac1 in PFK-depleted cells rescues reduced FA numbers and cell size. Quantifications of FAs per cell ( k ) and cell area ( l ) of U-2 OS cells transfected with control (−) or PFK-specific (+) siRNAs in combination with either eGFP or myc-Rac1-Q61L. Corresponding images are shown in Extended Data Fig. . Data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values (for k ): (siCtrl + GFP versus siCtrl + Rac1-Q61L) = 0.0342; (siCtrl + GFP versus siPFK + GFP) = 0.0063; (siCtrl + GFP versus siPFK + Rac1-Q61L) = 0.8904; P values (for l ): (siCtrl + GFP versus siCtrl + Rac1-Q61L) <0.0001; (siCtrl + GFP versus siPFK + GFP) = 0.0116; (siCtrl + GFP versus siPFK + Rac1-Q61L) = 0.0004). n.s., not significant; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. Scale bars, 25 µm.

Journal: Nature Cell Biology

Article Title: Fructose-1,6-bisphosphate couples glycolytic activity to cell adhesion

doi: 10.1038/s41556-026-01911-1

Figure Lengend Snippet: a , b , Addition of FBP to whole cell lysate causes a conformational change in Rac1. a , Whole cell lysates of U-2 OS cells were subjected to LiP–MS. Peptide intensity (amino acids (aa) 6–16) of Rac1 in response to increasing FBP concentrations. b , Responding peptide (red, aa 6–16) highlighted in the GTP-bound structure of Rac1 (PDB ID: 1MH1 ). c , Increased Rac1 activity upon loss of aldolase. Left: representative immunoblot of pull-down assay using GST-PAK-PBD beads to detect active Rac1 in lysates from siRNA treated U-2 OS cells. α-Tubulin was used as a loading control. Right: a quantification of Rac1-GTP over total Rac1. Data were normalized to siCtrl and represent mean ± s.e.m.; n = 5 independent experiments; two-sided one-sample t -test ( P value = 0.0326). d , Efficient Rac1 depletion. Representative immunoblot of U-2 OS cells treated with the indicated siRNAs. β-actin and clathrin heavy chain (CHC) were used as loading controls; N = 3 independent experiments. e , Codepletion of Rac1 does not significantly lower FBP levels in aldolase-knockdown cells. Relative FBP levels measured in U-2 OS cells treated with indicated siRNAs. Data were normalized to siCtrl and represent mean ± s.e.m.; n = 3 independent experiments; two-sided one-sample t -test ( P values: (siRAC1) = 0.1494; (siALDOA) = 0.027; (siRAC1 + siALDOA) = 0.105). f – h , Codepletion of Rac1 restores FA numbers and cell size in aldolase knockdown cells. f , Representative confocal images of paxillin-labelled FAs in U-2 OS cells treated with indicated siRNAs. FA segmentation and cell outlines (red) are shown below. g , h , A quantification of FAs per cell ( f ) and cell area ( g ) shown in f . For f – h , data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values (for g ): (siCtrl versus siRAC1) = 0.0481; (siCtrl versus siALDOA) <0.0001; (siCtrl versus siRAC1 + siALDOA) = 0.9979; P values (for h ): (siCtrl versus siRAC1) = 0.0003; (siCtrl versus siALDOA) <0.0001; (siCtrl versus siRAC1 + siALDOA) = 0.2799). i , j , Expression of dominant-negative Rac1 in aldolase-depleted cells rescues increased FA numbers ( i ) and cell size ( j ). A quantification of FAs per cell and cell area of U-2 OS cells transfected with control (−) or ALDOA-specific (+) siRNAs in combination with either eGFP or myc-Rac1-T17N. Corresponding images are shown in Extended Data Fig. . Data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values (for i ): (siCtrl + GFP versus siCtrl + T17N) = 0.1497; (siCtrl + GFP versus siALDOA + GFP) <0.0001; (siCtrl + GFP versus siALDOA + T17N) = 0.0633; P values (for j ): (siCtrl + GFP versus siCtrl + T17N) = 0.4683; (siCtrl + GFP versus siALDOA + GFP) <0.0001; (siCtrl + GFP versus siALDOA + T17N) = 0.0981). k , l , Expression of constitutively active Rac1 in PFK-depleted cells rescues reduced FA numbers and cell size. Quantifications of FAs per cell ( k ) and cell area ( l ) of U-2 OS cells transfected with control (−) or PFK-specific (+) siRNAs in combination with either eGFP or myc-Rac1-Q61L. Corresponding images are shown in Extended Data Fig. . Data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values (for k ): (siCtrl + GFP versus siCtrl + Rac1-Q61L) = 0.0342; (siCtrl + GFP versus siPFK + GFP) = 0.0063; (siCtrl + GFP versus siPFK + Rac1-Q61L) = 0.8904; P values (for l ): (siCtrl + GFP versus siCtrl + Rac1-Q61L) <0.0001; (siCtrl + GFP versus siPFK + GFP) = 0.0116; (siCtrl + GFP versus siPFK + Rac1-Q61L) = 0.0004). n.s., not significant; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. Scale bars, 25 µm.

Article Snippet: Cleared lysates were collected and incubated with 25 μg of GST-PAK-PBD beads (Cytoskeleton) for 1 h at 4 °C under constant rotation.

Techniques: Activity Assay, Western Blot, Pull Down Assay, Control, Knockdown, Expressing, Dominant Negative Mutation, Transfection

a , PFK depletion decreases the level of active Rac1. Left: Representative immunoblot of pulldown assay using GST-PAK-PBD beads to detect active Rac1 in lysates from U-2 OS cells treated with indicated siRNAs. β-actin was used as loading control. Right: Quantification of GTP-Rac1 over β-actin. Data were normalized to siCtrl and represent mean ± SEM; n = 5 independent biochemical experiments; two-sided One sample t-test ( P value = 0.0043). b-e , Co-depletion of Rac1 restores FA numbers and cell size upon aldolase knockdown also based on alternative Rac1-targeting siRNAs in RPE-1 cells. b , Representative confocal images of paxillin-labeled FAs in RPE-1 cells treated with indicated siRNAs. FA segmentation and cell outlines (red) are shown below. c, d , Quantification of FAs per cell and cell area shown in b . Data represent mean ± SEM; n = 3 (c: siRAC1#6, siRAC1#6 + siALDOA), 4 (c, all others), 5 (d: siRAC1#6, siRAC1#6 + siALDOA) or 6 (d, all others) independent experiments; statistical testing by mixed-effects model (REML) with Dunnett’s multiple comparison test ( P values ( c ): (siCtrl vs. siRAC1#5) = 0.6235; (siCtrl vs. siRAC1#6) = 0.4587; (siCtrl vs. siALDOA) = 0.0332; (siCtrl vs. siRAC1#5 + siALDOA) = 0.3327; (siCtrl vs. siRAC1#6 + siALDOA) = 0.9142; P values ( d ): (siCtrl vs. siRAC1#5) = 0.3583; (siCtrl vs. siRAC1#6) = 0.1119; (siCtrl vs. siALDOA) = 0.0006; (siCtrl vs. siRAC1#5 + siALDOA) = 0.8081; (siCtrl vs. siRAC1#6 + siALDOA) = 0.2114). Ns, not significant. e , Efficient Rac1 and aldolase depletion in RPE-1 cells. Immunoblot of RPE-1 cells treated with indicated siRNAs. CHC was used as loading control. N = 1 independent experiment. f , Expression of dominant-negative Rac1 in aldolase-depleted cells rescues FA number and cell size. Representative confocal images of paxillin-labeled FAs in U-2 OS cells transfected with control or ALDOA-specific siRNAs in combination with either eGFP or myc-Rac1-T17N. FA segmentation and cell outlines (red) are shown below. Corresponding quantification is shown in Fig. . g , Expression of constitutively active Rac1 in PFK depleted cells elevates FA number and cell size to normal levels. Representative confocal images of paxillin-labeled FAs in U-2 OS cells transfected with control or PFK-specific siRNAs in combination with either eGFP or myc-Rac1-Q61L. FA segmentation and cell outlines (red) are shown below. Corresponding quantification is shown in Fig. . Ns, not significant; *p < 0.05, **p < 0.01, ***p < 0.001. Scale bars, 25 µm.

Journal: Nature Cell Biology

Article Title: Fructose-1,6-bisphosphate couples glycolytic activity to cell adhesion

doi: 10.1038/s41556-026-01911-1

Figure Lengend Snippet: a , PFK depletion decreases the level of active Rac1. Left: Representative immunoblot of pulldown assay using GST-PAK-PBD beads to detect active Rac1 in lysates from U-2 OS cells treated with indicated siRNAs. β-actin was used as loading control. Right: Quantification of GTP-Rac1 over β-actin. Data were normalized to siCtrl and represent mean ± SEM; n = 5 independent biochemical experiments; two-sided One sample t-test ( P value = 0.0043). b-e , Co-depletion of Rac1 restores FA numbers and cell size upon aldolase knockdown also based on alternative Rac1-targeting siRNAs in RPE-1 cells. b , Representative confocal images of paxillin-labeled FAs in RPE-1 cells treated with indicated siRNAs. FA segmentation and cell outlines (red) are shown below. c, d , Quantification of FAs per cell and cell area shown in b . Data represent mean ± SEM; n = 3 (c: siRAC1#6, siRAC1#6 + siALDOA), 4 (c, all others), 5 (d: siRAC1#6, siRAC1#6 + siALDOA) or 6 (d, all others) independent experiments; statistical testing by mixed-effects model (REML) with Dunnett’s multiple comparison test ( P values ( c ): (siCtrl vs. siRAC1#5) = 0.6235; (siCtrl vs. siRAC1#6) = 0.4587; (siCtrl vs. siALDOA) = 0.0332; (siCtrl vs. siRAC1#5 + siALDOA) = 0.3327; (siCtrl vs. siRAC1#6 + siALDOA) = 0.9142; P values ( d ): (siCtrl vs. siRAC1#5) = 0.3583; (siCtrl vs. siRAC1#6) = 0.1119; (siCtrl vs. siALDOA) = 0.0006; (siCtrl vs. siRAC1#5 + siALDOA) = 0.8081; (siCtrl vs. siRAC1#6 + siALDOA) = 0.2114). Ns, not significant. e , Efficient Rac1 and aldolase depletion in RPE-1 cells. Immunoblot of RPE-1 cells treated with indicated siRNAs. CHC was used as loading control. N = 1 independent experiment. f , Expression of dominant-negative Rac1 in aldolase-depleted cells rescues FA number and cell size. Representative confocal images of paxillin-labeled FAs in U-2 OS cells transfected with control or ALDOA-specific siRNAs in combination with either eGFP or myc-Rac1-T17N. FA segmentation and cell outlines (red) are shown below. Corresponding quantification is shown in Fig. . g , Expression of constitutively active Rac1 in PFK depleted cells elevates FA number and cell size to normal levels. Representative confocal images of paxillin-labeled FAs in U-2 OS cells transfected with control or PFK-specific siRNAs in combination with either eGFP or myc-Rac1-Q61L. FA segmentation and cell outlines (red) are shown below. Corresponding quantification is shown in Fig. . Ns, not significant; *p < 0.05, **p < 0.01, ***p < 0.001. Scale bars, 25 µm.

Article Snippet: Cleared lysates were collected and incubated with 25 μg of GST-PAK-PBD beads (Cytoskeleton) for 1 h at 4 °C under constant rotation.

Techniques: Western Blot, Control, Knockdown, Labeling, Comparison, Expressing, Dominant Negative Mutation, Transfection

a , b , Codepletion of Rac1 in aldolase-treated cells normalizes F-actin organization and cell protrusion. a , Representative confocal images of the phalloidin-labelled F-actin cytoskeleton in U-2 OS cells treated with indicated siRNAs. Zoom-ins of orange boxes are shown. b , A quantification of the protrusive area of U-2 OS cells treated with indicated siRNAs. Data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values: (siCtrl versus siRAC1) = 0.5925; (siCtrl versus siALDOA) <0.0001; (siCtrl versus siRAC1 + siALDOA) = 0.0825). Corresponding images are shown in Extended Data Fig. . c , d , Codepletion of Rac1 in aldolase-depleted cells restores cell spreading to normal levels. c , Representative confocal images of phalloidin-labelled U-2 OS cells treated with indicated siRNAs. The cells were seeded and fixed after indicated time points. d , A quantification of cell spreading shown in c . Data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values: (siCtrl versus siRAC1) = 0.7944; (siCtrl versus siALDOA) <0.0001; (siCtrl versus siRAC1 + siALDOA) = 0.6024). e , f , Glucose triggers cell spreading. e , Representative images of phalloidin-labelled RPE-1 cells incubated with the indicated glucose concentrations. The cells were seeded and fixed after 2 h. f , A quantification of cell spreading shown in e . Data represent mean ± s.e.m.; n = 3 independent experiments; two-sided unpaired t -test ( P value = 0.0012). g , h , Increased Rac1 activity upon glucose. g , Representative immunoblot of a pull-down assay using GST-PAK-PBD beads to detect active GTP-Rac1 in lysates from untreated or glucose exposed RPE-1 cells. β-actin was used as a loading control. h , A quantification of GTP-Rac1 over total Rac1. The data were normalized to 0 mM glucose condition and represent mean ± s.e.m.; n = 3 independent experiments; two-sided one-sample t -test ( P value = 0.0228). n.s., not significant; * P < 0.05, ** P < 0.01, **** P < 0.0001. Scale bars, 25 µm for a and c ; 10 µm for e .

Journal: Nature Cell Biology

Article Title: Fructose-1,6-bisphosphate couples glycolytic activity to cell adhesion

doi: 10.1038/s41556-026-01911-1

Figure Lengend Snippet: a , b , Codepletion of Rac1 in aldolase-treated cells normalizes F-actin organization and cell protrusion. a , Representative confocal images of the phalloidin-labelled F-actin cytoskeleton in U-2 OS cells treated with indicated siRNAs. Zoom-ins of orange boxes are shown. b , A quantification of the protrusive area of U-2 OS cells treated with indicated siRNAs. Data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values: (siCtrl versus siRAC1) = 0.5925; (siCtrl versus siALDOA) <0.0001; (siCtrl versus siRAC1 + siALDOA) = 0.0825). Corresponding images are shown in Extended Data Fig. . c , d , Codepletion of Rac1 in aldolase-depleted cells restores cell spreading to normal levels. c , Representative confocal images of phalloidin-labelled U-2 OS cells treated with indicated siRNAs. The cells were seeded and fixed after indicated time points. d , A quantification of cell spreading shown in c . Data represent mean ± s.e.m.; n = 5 independent experiments; one-way ANOVA with Dunnett’s post-test ( P values: (siCtrl versus siRAC1) = 0.7944; (siCtrl versus siALDOA) <0.0001; (siCtrl versus siRAC1 + siALDOA) = 0.6024). e , f , Glucose triggers cell spreading. e , Representative images of phalloidin-labelled RPE-1 cells incubated with the indicated glucose concentrations. The cells were seeded and fixed after 2 h. f , A quantification of cell spreading shown in e . Data represent mean ± s.e.m.; n = 3 independent experiments; two-sided unpaired t -test ( P value = 0.0012). g , h , Increased Rac1 activity upon glucose. g , Representative immunoblot of a pull-down assay using GST-PAK-PBD beads to detect active GTP-Rac1 in lysates from untreated or glucose exposed RPE-1 cells. β-actin was used as a loading control. h , A quantification of GTP-Rac1 over total Rac1. The data were normalized to 0 mM glucose condition and represent mean ± s.e.m.; n = 3 independent experiments; two-sided one-sample t -test ( P value = 0.0228). n.s., not significant; * P < 0.05, ** P < 0.01, **** P < 0.0001. Scale bars, 25 µm for a and c ; 10 µm for e .

Article Snippet: Cleared lysates were collected and incubated with 25 μg of GST-PAK-PBD beads (Cytoskeleton) for 1 h at 4 °C under constant rotation.

Techniques: Incubation, Activity Assay, Western Blot, Pull Down Assay, Control